SCHEMBL23129174

SCHEMBL23129174

c1ccc(-c2nc(-n3c4cc5ccccc5cc4c4c5c6ccccc6c6ccccc6c5ccc43)nc3c2oc2ccccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.36
MAPT P10636 10/20 0.36
KMT2A Q03164 5/20 0.36
MEN1 O00255 4/20 0.36
CSF1R P07333 1/20 0.36
PDGFRB P09619 1/20 0.36
KIT P10721 1/20 0.36
FLT3 P36888 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
ALDH1A1 P00352 4/20 0.34
LMNA P02545 4/20 0.34
KDM4E B2RXH2 3/20 0.34
POLB P06746 2/20 0.34
HSD17B10 Q99714 2/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34
ADORA2A P29274 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
USP2 O75604 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23983952 0.98 TSHR (0.35) TSHRMAPTKMT2AMEN1CSF1R
SCHEMBL23984002 0.93 TSHR (0.34) TSHRMAPTKMT2AMEN1CSF1R
SCHEMBL23129089 0.92 NPC1 (0.35) TSHRMAPTKMT2AMEN1ALDH1A1
SCHEMBL23983609 0.91 TSHR (0.31) TSHRKMT2AMEN1ALDH1A1KDM4E
SCHEMBL23984332 0.90 NPC1 (0.32) TSHRMAPTKMT2AMEN1ALDH1A1
SCHEMBL23983592 0.90 TSHR (0.31) TSHR
SCHEMBL23129092 0.90 TSHR (0.38) TSHRMAPTKMT2AMEN1CSF1R
SCHEMBL20226383 0.89 TSHR (0.39) TSHRMAPTKMT2AMEN1CSF1R
SCHEMBL21736119 0.89 MAPT (0.42) TSHRMAPTKMT2AMEN1CSF1R
SCHEMBL23983960 0.89 KDM4E (0.32) TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858947-B2 Heterocyclic compound and organic light emitting device including the same LG CHEM, LTD. (KR) 2024-01-02 US disclosed
US-11858947-B2 Heterocyclic compound and organic light emitting device including the same LG CHEM, LTD. (KR) 2024-01-02 US disclosed
US-20210340159-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG CHEM, LTD. (KR) 2021-11-04 US disclosed
EP-3795569-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LG CHEM, LTD. (KR) 2021-03-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210340159-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME NR4A1, CYP1A1, ARNT TSHR 2003/4885MAPT 3330/4885KMT2A 1646/4885
US-11858947-B2 Heterocyclic compound and organic light emitting device including the same NR4A1, CYP1A1, ARNT TSHR 2003/4885MAPT 3330/4885KMT2A 1646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.